Cancer Center of Central Connecticut — Southington, Connecticut

Cancer Center of Central Connecticut is a clinical research site located in Southington, Connecticut, United States 06489.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Cancer Center of Central Connecticut has participated in 20 clinical trials.

Therapeutic areas: Metastatic Breast Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer.

Sponsors: Pfizer, Millennium Pharmaceuticals, Inc., Celgene.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Center of Central Connecticut?

Cancer Center of Central Connecticut has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Center of Central Connecticut conducted?

Cancer Center of Central Connecticut has 20 clinical trials on record. Their work covers Metastatic Breast Cancer, Multiple Myeloma, Non-Small Cell Lung Cancer.

Is Cancer Center of Central Connecticut accredited by Crixeo Health?

Yes — Cancer Center of Central Connecticut holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cancer Center of Central Connecticut?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.